Azizova, Aynur;
Wamelink, Ivar JHG;
Prysiazhniuk, Yeva;
Cakmak, Marcus;
Kaya, Elif;
Petr, Jan;
Barkhof, Frederik;
(2024)
Human performance in predicting enhancement quality of gliomas using gadolinium-free MRI sequences.
Journal of Neuroimaging
, 34
(6)
pp. 673-693.
10.1111/jon.13233.
Preview |
Text
Barkhof_Journal of Neuroimaging - 2024 - Azizova - Human performance in predicting enhancement quality of gliomas using.pdf Download (2MB) | Preview |
Abstract
BACKGROUND AND PURPOSE: To develop and test a decision tree for predicting contrast enhancement quality and shape using precontrast magnetic resonance imaging (MRI) sequences in a large adult-type diffuse glioma cohort. METHODS: Preoperative MRI scans (development/optimization/test sets: n = 31/38/303, male = 17/22/189, mean age = 52/59/56.7 years, high-grade glioma = 22/33/249) were retrospectively evaluated, including pre- and postcontrast T1-weighted, T2-weighted, fluid-attenuated inversion recovery, and diffusion-weighted imaging sequences. Enhancement prediction decision tree (EPDT) was developed using development and optimization sets, incorporating four imaging features: necrosis, diffusion restriction, T2 inhomogeneity, and nonenhancing tumor margins. EPDT accuracy was assessed on a test set by three raters of variable experience. True enhancement features (gold standard) were evaluated using pre- and postcontrast T1-weighted images. Statistical analysis used confusion matrices, Cohen's/Fleiss’ kappa, and Kendall's W. Significance threshold was p < .05. RESULTS: Raters 1, 2, and 3 achieved overall accuracies of .86 (95% confidence interval [CI]: .81-.90), .89 (95% CI: .85-.92), and .92 (95% CI: .89-.95), respectively, in predicting enhancement quality (marked, mild, or no enhancement). Regarding shape, defined as the thickness of enhancing margin (solid, rim, or no enhancement), accuracies were .84 (95% CI: .79-.88), .88 (95% CI: .84-.92), and .89 (95% CI: .85-.92). Intrarater intergroup agreement comparing predicted and true enhancement features consistently reached substantial levels (≥.68 [95% CI: .61-.75]). Interrater comparison showed at least moderate agreement (group: ≥.42 [95% CI: .36-.48], pairwise: ≥.61 [95% CI: .50-.72]). Among the imaging features in the EPDT, necrosis assessment displayed the highest intra- and interrater consistency (≥.80 [95% CI: .73-.88]). CONCLUSION: The proposed EPDT has high accuracy in predicting enhancement patterns of gliomas irrespective of rater experience.
| Type: | Article |
|---|---|
| Title: | Human performance in predicting enhancement quality of gliomas using gadolinium-free MRI sequences |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1111/jon.13233 |
| Publisher version: | https://doi.org/10.1111/jon.13233 |
| Language: | English |
| Additional information: | © 2024 The Author(s). Journal of Neuroimaging published by Wiley Periodicals LLC on behalf of American Society of Neuroimaging. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| Keywords: | Enhancement, gadolinium-based contrast agent, GBCA, glioma, MRI, VASARI |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Brain Repair and Rehabilitation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10200722 |
Archive Staff Only
 |
View Item |
